Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 97-108 of 1584 results.
"We conducted a quality improvement project at Evelina London Children's Hospital, aiming to reduce UVC-related complications by introducing routine monitoring of UVC tip position after insertion using point-of-care ultrasound (POCUS)” Gallo et al (2026).
"Our study supports transhepatic hemodialysis catheters as a viable option for patients with no other access options, showing good long-term functionality, low infection rates, and reasonable dialysis adequacy” Freitas et al (2026).
"This study aimed to systematically analyze the epidemiology, pathogen distribution, and independent predictors of 28-day mortality in CRBSI to support early risk warning and precise intervention” Li et al (2026).
"This project highlights the importance of improving nurses' competency in CDE management through OSCE and MFS. Additionally, the development of patient-centered educational materials enhanced patients' understanding of chemotherapy extravasation risks, thereby contributing to improved patient safety and quality of care” Wang et al (2026).
"We report a case with clinical side effects related to extravasation of 177Lu-PSMA (estimated activity of 2.25 GBq) after administration via the cubital vein” Corveleyn et al (2026).
"Our study aimed to reproduce in vitro the cross-transmission of bacteria from dry surfaces to invasive medical devices via healthcare professional's gloves” Lebielle et al (2026).
"To determine the feasibility of using a single use elastomeric pump (EP) to deliver CSCI medication for 24 hours, as an alternative to syringe drivers (SDs) at discharge” Gover et al (2026).
"Overall, findings support the technical feasibility of utilizing this combination of elastomeric pump and conditions for administration of cetuximab and trastuzumab, providing valuable insights into maintaining product stability outside traditional healthcare settings” Taherian et al (2026).
"Findings support the clinical and economic value of PORTs for long-term chemotherapy, difficult venous access, and low-maintenance needs, whereas PICCs suit shorter treatment durations, patients unsuitable for minor surgery, or settings favoring bedside insertion" Rognoni et al (2026).
"To determine the concentration and formulation of chlorhexidine gluconate (CHG) or povidone-iodine (PVI) associated with the lowest incidence of catheter-related infections (CRIs)" Drugeon et al (2026).
"Patients with difficult intravenous access (DIVA) are at increased risk of delays, discomfort and complications due to multiple failed intravenous access attempts. However, evidence comparing commonly used alternatives, short midline catheters (SMLs) and central venous catheters (CVCs) in this population is limited" Mellander et al (2026).
"A rule-based chatbot designed to support PICC self-management demonstrates potential to enhance information accessibility, provide practical guidance, and offer psychosocial support” Jo et al (2026).
